Here, we demonstrate that p300 is a general epigenetic suppressor of MDS progression using 4 clinically relevant, genetically engineered MDS mouse models: Tet2+/–, Tet2–/–, Asxl1+/– and Srsf2P59H. Here, ASXL1 is linked to myelodysplastic syndrome.